Hm Payson & CO Merck & Co., Inc. Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hm Payson & CO holds 650,806 shares of MRK stock, worth $63.7 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

650,806

Previous 557,405 16.76%

Holding current value

$63.7 Million

Previous $69 Million 7.1%

% of portfolio

1.27%

Previous 1.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$111.15 - $128.97 $10.4 Million - $12 Million	93,401 Added 16.76%	650,806 $73.9 Million
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $378,332 - $406,325	3,056 Added 0.55%	557,405 $69 Million
Q1 2024 Jun 20, 2024	SELL	$113.24 - $131.95 $1.83 Million - $2.13 Million	-16,175 Reduced 2.84%	554,349 $73.1 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $4.67 Million - $5.09 Million	46,666 Added 8.91%	570,524 $62.2 Million
Q3 2023 Nov 06, 2023	BUY	$102.95 - $114.33 $24.8 Million - $27.6 Million	241,222 Added 85.35%	523,858 $53.9 Million
Q2 2023 Jul 17, 2023	BUY	$108.61 - $118.38 $996,713 - $1.09 Million	9,177 Added 3.36%	282,636 $32.6 Million
Q1 2023 Apr 18, 2023	BUY	$102.94 - $114.86 $1.29 Million - $1.44 Million	12,535 Added 4.8%	273,459 $29.1 Million
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $4.42 Million - $5.66 Million	50,527 Added 24.02%	260,924 $28.9 Million
Q3 2022 Oct 25, 2022	SELL	$84.53 - $94.96 $631,270 - $709,161	-7,468 Reduced 3.43%	210,397 $18.1 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $200,292 - $227,041	-2,399 Reduced 1.09%	217,865 $19.9 Million
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $59,469 - $66,661	-809 Reduced 0.37%	220,264 $18.1 Million
Q4 2021 Feb 15, 2022	SELL	$72.28 - $90.54 $952,650 - $1.19 Million	-13,180 Reduced 5.63%	221,073 $16.9 Million
Q3 2021 Nov 30, 2021	SELL	$71.68 - $78.83 $4.62 Million - $5.08 Million	-64,410 Reduced 21.57%	234,253 $17.6 Million
Q2 2021 Aug 17, 2021	SELL	$70.31 - $77.77 $488,162 - $539,957	-6,943 Reduced 2.27%	298,663 $23.2 Million
Q1 2021 Jun 15, 2021	SELL	$68.86 - $81.11 $661,606 - $779,304	-9,608 Reduced 3.05%	305,606 $23.6 Million
Q4 2020 Mar 10, 2021	SELL	$71.77 - $79.65 $280,620 - $311,431	-3,910 Reduced 1.23%	315,214 $25.8 Million
Q3 2020 Dec 21, 2020	BUY	$73.18 - $82.95 $2.48 Million - $2.81 Million	33,855 Added 11.87%	319,124 $26.5 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $980,035 - $1.12 Million	-13,917 Reduced 4.65%	285,269 $22.1 Million
Q1 2020 Jul 01, 2020	SELL	$63.36 - $87.82 $583,989 - $809,436	-9,217 Reduced 2.99%	299,186 $23 Million
Q4 2019 Feb 18, 2020	BUY	$77.58 - $87.54 $85,105 - $96,031	1,097 Added 0.36%	308,403 $28 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $882,832 - $962,319	11,604 Added 3.92%	307,306 $25.9 Million
Q2 2019 Aug 15, 2019	SELL	$69.84 - $81.59 $223,488 - $261,088	-3,200 Reduced 1.07%	295,702 $24.8 Million
Q1 2019 Jul 31, 2019	BUY	$69.58 - $79.36 $20.5 Million - $23.4 Million	295,032 Added 7623.57%	298,902 $24.9 Million
Q4 2018 Feb 15, 2019	SELL	$65.24 - $75.71 $21 Million - $24.3 Million	-321,592 Reduced 98.81%	3,870 $296,000
Q3 2018 Nov 30, 2018	SELL	$57.69 - $67.84 $4.29 Million - $5.04 Million	-74,346 Reduced 18.6%	325,462 $23.1 Million
Q2 2018 Aug 27, 2018	SELL	$50.83 - $59.72 $62,317 - $73,216	-1,226 Reduced 0.31%	399,808 $24.3 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $1.12 Million - $1.3 Million	21,890 Added 5.77%	401,034 $21.8 Million
Q4 2017 Feb 16, 2018	BUY	$51.62 - $61.64 $986,354 - $1.18 Million	19,108 Added 5.31%	379,144 $21.3 Million
Q3 2017 Nov 06, 2017	BUY	$58.67 - $63.13 $21.1 Million - $22.7 Million	360,036	360,036 $23.1 Million

Others Institutions Holding MRK

# of Institutions

3,816

Shares Held

1.86B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account